<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The development of a totally subcutaneous implantable defibrillator (S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) system requires a new approach for <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> detection </plain></SENT>
<SENT sid="1" pm="."><plain>To evaluate <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> discrimination of one such system, the Subcutaneous versus Transvenous <z:hpo ids='HP_0011675'>Arrhythmia</z:hpo> Recognition Testing (START) study was designed as a prospective, multicenter trial comparing simulated sensing performances of the S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> system with single- (SC-TV) and dual-chamber transvenous (DC-TV) implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) systems </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: At <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation, induced ventricular and atrial <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> were recorded simultaneously in transvenous (right ventricular [RV] → superior vena cava [SVC]+ Coil) and cutaneous electrode configurations </plain></SENT>
<SENT sid="3" pm="."><plain>Recorded signals of ventricular (n = 46) and atrial <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> (n = 50) with ventricular rates &gt;170 bpm from 64 patients were used to compare detection performance of the S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> system with TV-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> systems from 3 manufacturers </plain></SENT>
<SENT sid="4" pm="."><plain>Appropriate detection of ventricular tachyarrhythmias was assessed with devices programmed in single-zone (rate ≥ 170 bpm) and dual-zone configurations (<z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> ≥ 240 bpm; <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> ≥ 170 bpm) </plain></SENT>
<SENT sid="5" pm="."><plain>S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> specificity performance for <z:hpo ids='HP_0005115'>supraventricular arrhythmias</z:hpo> was compared to single- and dual-chamber devices in a dual-zone configuration </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Appropriate detection of ventricular tachyarrhythmias for subcutaneous and TV devices in single- and dual-zone configurations was 100% and &gt;99%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Specificity for <z:hpo ids='HP_0005115'>supraventricular arrhythmias</z:hpo> was significantly better for the S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> system compared to 2 of 3 TV systems, as well as the composite of TV devices (98.0%[S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>] vs 76.7%[SC-TV range: 64.0-92.0%] vs 68.0%[DC-TV range: 32.7-89.8%; P &lt; 0.001]) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Appropriate <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> detection is excellent for <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> systems evaluated; however, specificity of <z:hpo ids='HP_0005115'>supraventricular arrhythmia</z:hpo> discrimination by the S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> system is better than discrimination by 2 of 3 TV systems </plain></SENT>
</text></document>